Typical Meningioma (TM)
Last Updated: March 27, 2020
- Benign, slow-growing extra-axial tumor arising from arachnoid meningothelial (“cap”) cells
- Most common primary adult intracranial neoplasm
- WHO grade I
- Overwhelming majority are supratentorial (~90%): parasagittal, convexity, sphenoid wing, olfactory groove
- Infratentorial (~10%): most commonly within the CPA cistern
- Optic nerve sheath or intraventricular locations may be seen
- Uncommonly arise extracranially: sinonasal, parotid, intraoasseous, or skin
- Single or multiple
- Associated with Neurofibromatosis type 2 (NF-2)
- “Tumor to tumor” metastases to meningioma may be seen (“collision tumor”), most commonly from breast or lung
- Adults are most commonly affected (40-60 years); children in cases of NF-2
- Female gender predilection (M:F 1:2-3)
- Presenting symptoms dependent on tumor size and location
- Majority of TMs are asymptomatic
- Mass effect on adjacent structures resulting in seizures, hemiparesis, visual field defects, cranial nerve defects
- Treatment: serial imaging if small, asymptomatic; surgical resection including dural tail if symptomatic
- Well-marginated, smooth extra-axial mass with broad dural attachment
- ± Bucking or hyperostosis of adjacent cortex
- Avid, homogeneous enhancement is typical
- Intra-osseous extension and dural venous sinus involvement or compression may be present
- Well-marginated, iso- to hyperdense mass with broad dural attachment
- Variable patterns of calcification common (focal, diffuse, rim, etc.)
- Hypodense peritumoral edema sometimes present
- ± Hyperostosis of adjacent bone
- T1WI: iso- to hypointense mass; hyperintense areas of calcification
- T2WI: variable signal intensity; ± cystic areas and hyperintense “CSF cleft” separating tumor from adjacent brain
- FLAIR: hyperintense peritumoral edema may be present
- T2*GRE: hypointense signal “blooming” related to calcification
- DWI: variable reduction in diffusivity
- T1WI+C: avid, homogeneous enhancement; ±“dural tail” (nonspecific finding)
- MR Venogram: evaluate patency and involvement of dural venous sinuses
- MR spectroscopy: elevated alanine at short echo times results in triplet peaks at 1.3-1.5 ppm
- MRI without and with IV contrast; MR spectroscopy may be helpful to differentiate from other tumor types if ambiguous
For more information, please see the corresponding chapter in Radiopaedia.
Contributor: Rachel Seltman, MD
Bosch MM, et al. Optic nerve sheath meningiomas in patients with neurofibromatosis type 2. Arch Ophthalmol. 2006;124:379-385.
Buetow MP, et al. Atypical, typical, and misleading features in meningioma. Radiographics 1991;11:1087-1106.
Lin BJ, et al. Correlation between magnetic resonance imaging grading and pathological grading in meningioma. J Neurosurg. 2014;121:1201-1208.
Osborn AG, Salzman K L, Jhaveri MD. Diagnostic Imaging (3rd ed). Philadelphia, PA: Elsevier, 2016.
Shibuya M. Pathology and molecular genetics of meningioma: recent advances. Neurol Med Chir (Tokyo). 2015;55:14-27.
Takeguchi T, et al. The dural tail of intracranial meningiomas on fluid-attenuated inversion-recovery images. Neuroradiology. 2004;46:130-135.
Zhang H, et al. Perfusion MR imaging for differentiation of benign and malignant meningiomas. Neuroradiology. 2008;50(6):525-530.
Zhang H, et al. Preoperative subtyping of meningiomas by perfusion MR imaging. Neuroradiology. 2008;50:835-840.
Please login to post a comment.